| scholarly article | Q13442814 |
| P50 | author | Nathan Lawrentschuk | Q37830122 |
| Shomik Sengupta | Q51742478 | ||
| P2093 | author name string | Richard Jones | |
| Raj Persad | |||
| Jim Barber | |||
| Simon P Kim | |||
| Paul Davis | |||
| Damien Bolton | |||
| Luke Hounsome | |||
| Weranja K B Ranasinghe | |||
| P2860 | cites work | Screening for prostate cancer | Q24201690 |
| Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion | Q24620320 | ||
| Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005 | Q24656098 | ||
| American Cancer Society guideline for the early detection of prostate cancer: update 2010 | Q28274848 | ||
| Screening and prostate-cancer mortality in a randomized European study | Q29617485 | ||
| Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force | Q33357480 | ||
| Complications after prostate biopsy: data from SEER-Medicare | Q34029816 | ||
| Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force | Q34044753 | ||
| Prostate-cancer mortality at 11 years of follow-up | Q34261229 | ||
| Quality-of-life effects of prostate-specific antigen screening. | Q34294102 | ||
| Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology | Q35673265 | ||
| Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up | Q35677465 | ||
| Complications of transrectal versus transperineal prostate biopsy | Q36058996 | ||
| Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50. | Q36142693 | ||
| Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study | Q36378954 | ||
| EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease | Q37807744 | ||
| Risk-based prostate cancer screening. | Q37963657 | ||
| Patient acceptance of active surveillance as a treatment option for low‐risk prostate cancer | Q39758890 | ||
| Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam). | Q51584281 | ||
| Does active surveillance for men with localized prostate cancer carry psychological morbidity? | Q53189394 | ||
| Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors | Q57646929 | ||
| P433 | issue | 1 | |
| P921 | main subject | Australia | Q408 |
| P304 | page(s) | 77-83 | |
| P577 | publication date | 2013-10-31 | |
| P1433 | published in | BJU International | Q4835773 |
| P1476 | title | Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia | |
| P478 | volume | 113 |
| Q36199134 | An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? |
| Q55046877 | An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry |
| Q36680640 | Australian patterns of prostate cancer care: Are they evolving? |
| Q34086144 | Cancer Screening among immigrants living in urban and regional Australia: results from the 45 and up study |
| Q33783979 | In older men, lower plasma 25-hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancer |
| Q33904126 | Increasing detection of significant prostate cancer in younger men - ten year trends in prostate cancer risk profile in the Mid-West of Ireland |
| Q42219662 | Practice patterns of urologists in managing Korean men aged 40 years or younger with high serum prostate-specific antigen levels. |
| Q40803697 | Prostate cancer in men aged less than 50 years at diagnosis. |
| Q30698121 | Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. |
| Q39526823 | Prostate cancer outcomes for men who present with symptoms at diagnosis. |
| Q35096442 | Prostate cancer screening in Primary Health Care: the current state of affairs. |
| Q38210857 | Prostate cancer: measuring PSA. |
| Q47966928 | Survival outcomes in elderly men undergoing radical prostatectomy in Australia. |
| Q38402732 | Young-age prostate cancer. |
Search more.